Logo
x

Search

Subscribe Now

Solid Tumors

Coherus BioSciences to Acquire Surface Oncology for ~$65M

Coherus BioSciences to Acquire Surface Oncology for ~$65M

  • June 19, 2023
PharmaShots Interview: Ikena Oncology’ Mark Manfredi Shares Insight on IK-930 for the Treatment of Solid Tumors

PharmaShots Interview: Ikena Oncology’ Mark Manfredi Shares Insight on IK-930 for the Treatment of Solid Tumors

  • April 5, 2022
Pyxis Oncology In-Licenses BSI-060T From Biosion for the Treatment of Solid Tumors

Pyxis Oncology In-Licenses BSI-060T From Biosion for the Treatment of Solid Tumors

  • March 30, 2022
Sotio Signs a Multiple Agreement with LegoChem Biosciences to Develop Novel Therapeutics for the Treatment of Solid Tumors

Sotio Signs a Multiple Agreement with LegoChem Biosciences to Develop Novel Therapeutics for the Treatment of Solid Tumors

  • November 17, 2021
Takeda to Acquire GammaDelta to Advance the Development of Allogeneic ?dT Cell Therapies for the Treatment of Solid Tumors

Takeda to Acquire GammaDelta to Advance the Development of Allogeneic ?dT Cell Therapies for the Treatment of Solid Tumors

  • October 28, 2021
Turning Point Presents Results of Repotrectinib in P-I/II TRIDENT-1 Study for the Treatment of Solid Tumors at AACR-NCI-EORTC 2021

Turning Point Presents Results of Repotrectinib in P-I/II TRIDENT-1 Study for the Treatment of Solid Tumors at AACR-NCI-EORTC 2021

  • October 11, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.